Loading provider…
Loading provider…
Hematology & Oncology Physician in Dallas, TX
NPI: 1194011924Primary Practice Location
METHODIST MANSFIELD MEDICAL CENTER
2700 E Broad St, Mansfield, TX
Primary Employer
Texas Oncology PA
texasoncology.com
HQ Phone
Get MD Ananth's Phone Numberphone_androidMobile
Get MD Ananth's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardTX State Medical License
TX State Medical License
2018 - 2026
PA State Medical License
2015 - 2018
MO State Medical License
2014 - 2016

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Texas A&M College of Medicine - Bryan
medicine.tamu.edu
Medical School
Until 2011
Washington University/B-JH/SLCH Consortium
Residency • Internal Medicine
2011 - 2014
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 202 | 595 |
| 2 | 36415Insertion of needle into vein for collection of blood sample | 191 | 564 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 147 | 223 |
| 4 | 99214Established patient office or other outpatient visit, 30-39 minutes | 131 | 307 |
| 5 | 80053Blood test, comprehensive group of blood chemicals | 80 | 123 |
Authors: Richard Erickson, Adam Wood, Jonathan Ramirez, Michelle Thompson
Journal: J Clin Gastroenterol
Central Nervous System Involvement by Waldenstrom Macroglobulinemia: A Case Report of the Bing-Neel Syndrome.
Authors: Ananth Arjunan, Hema Rai
Publication Date: 2018-09-13
High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid features.
Authors: Leonard Appleman, Tala Achkar, Rahul Parikh, David Friedland, Diwakar Davar
Journal: PLoS One
Publication Date: 2017-12-20
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Abemaciclib, DRUG: Standard Adjuvant ET
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Abemaciclib, DRUG: Exemestane, DRUG: Fulvestrant, DRUG: Imlunestrant